AMCX three-lens brief
Evidence-based stock research on AMCX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 11.38% in the last session — a material single-day move. · Trading >3% below the 50-day MA — short-term weakness.
- Price up 11.38% in the last session — a material single-day move.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 17.4pp over 30 days.
- P/E of 11.6 — trading at a value multiple.
- Reported earnings on 2026-11-09.
AMCX closed at $9.59 (+11.38%) as of 2026-11-12. Market cap: $394.72M. P/E (trailing) 11.6. Price is below the 50-day MA and above the 200-day MA. Positives: price up 11.38% in the last session — a material single-day move.; p/E of 11.6 — trading at a value multiple.. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 17.4pp over 30 days.. Last quarter: Revenue $566.07M, net income -$47.39M, free cash flow $883.68M.
Why three lenses on AMCX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMCX across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AMCX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMCX brief"></iframe>